Search the site

Sydney Brenner Institute for Molecular Bioscience Enabling the development of new and innovative solutions to some of Africa’s greatest health challenges

Start main page content

News and Events

Dr Raylton Chikwati postdoc SBIMB published in Lancet Global Health on type 2 diabetes 600x300

Study shows type 2 diabetes doubled in sub-Saharan Africa in 6 years

27/02/2025

Poorly controlled type 2 diabetes can, over time, increase the risk of heart and kidney disease and lead to eye, vascular and nerve damage.

Professor Collen Masimirembwa of the SBIMB won the Pioneer Award for research in pharmacogenomics.600x300

Award-winning pharmaco-geneticist advances drug discovery and development for Africans

20/02/2025

Professor Collen Masimirembwa of the Sydney Brenner Institute for Molecular Bioscience receives Precision Medicine World Conference Pioneer Award (PMWC) 2025.

Scientists at SBIMB coauthored Expanding the human gut microbiome atlas of Africa published in Nature

Africa’s largest human microbiome study sheds light on gut diversity and health

30/01/2025

The most extensive study of the gut microbiome in Africa has discovered new microbial species and never-before-reported metagenomes* from several African sites.

Largest study of its kind in Africa finds African men have high risk of prostate cancer, earlier

09/10/2024

Researchers have identified the genetic risk factors that contribute to prostate cancer in a diverse group of African men.

Some of the speakers presenting at the SBIMB syposium titled Enabling a Precision Medicine Approach in African Populations, which precedes the launch of a new research lab.

New Wits laboratory will advance African genetics research

11/10/2021

The Sydney Brenner Institute for Molecular Bioscience today launches a new research lab to understand African genetics and advance precision medicine in Africa.

Variant Bio Launches New Partnership on Kidney Disease in South Africa

02/08/2021

Variant Bio is excited to announce the first research project in South Africa through a partnership with the African Research on Kidney Disease (ARK) Consortium